Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES : revenue, balance sheet and financial ratios

EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES is a French company founded 15 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in NEUILLY-SUR-SEINE (92200), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES (SIREN 523894269)
Indicator 2016
Revenue N/C
Net income 0 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2016, EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 2%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 2%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2016) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

2.305%

Financial autonomy (2016) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

2.135%

Asset age ratio (2016) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

58.0%

Solvency indicators evolution
EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES

Sector positioning

Debt ratio
2.31 2016
2016
Q1: 0.0
Med: 4.56
Q3: 49.06
Good

In 2016, the debt ratio of EDR PHARMA ETUDES DEVELOP... (2.31) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
2.13% 2016
2016
Q1: 3.8%
Med: 30.97%
Q3: 62.12%
Average

In 2016, the financial autonomy of EDR PHARMA ETUDES DEVELOP... (2.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1199.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2016) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1199.818

Liquidity indicators evolution
EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES

Sector positioning

Liquidity ratio
1199.82 2016
2016
Q1: 129.9
Med: 224.7
Q3: 449.36
Excellent

In 2016, the liquidity ratio of EDR PHARMA ETUDES DEVELOP... (1199.82) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES in its sector

Comparison with sector Activités spécialisées, scientifiques et techniques diverses

Similar companies (Activités spécialisées, scientifiques et techniques diverses)

Compare EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES with other companies in the same sector:

Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses

Frequently asked questions about EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES

What is the revenue of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES ?

The revenue of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES is not publicly disclosed (confidential accounts filed with INPI).

Is EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES profitable?

Profitability information is not publicly available.

Where is the headquarters of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES ?

The headquarters of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES is located in NEUILLY-SUR-SEINE (92200), in the department Hauts-de-Seine.

Where to find the tax return of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES ?

The tax return of EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES operate?

EDR PHARMA ETUDES DEVELOPPEMENTS ET REGLEMENTATION PHARMACEUTIQUES operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.